Gene · 53353
Papers2,235
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,235
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unraveling EGFR-TKI resistance in lung cancer with high PD-L1 or TMB in EGFR-sensitive mutations. | Respir Res | 2024 | 38238740 | PubTator, text mining | PubMed |
| A novel transformer-based aggregation model for predicting gene mutations in lung adenocarcinoma. | Med Biol Eng Comput | 2024 | 38233683 | PubTator, text mining | PubMed |
| Comprehensive analyses of mitophagy-related genes and mitophagy-related lncRNAs for patients with ovarian cancer. | BMC Womens Health | 2024 | 38218807 | PubTator, text mining | PubMed |
| Clinical and molecular characteristics of RNF43 mutations as promising prognostic biomarkers in colorectal cancer. | Ther Adv Med Oncol | 2024 | 38205077 | PubTator, text mining | PubMed |
| MET fusions are targetable genomic variants in the treatment of advanced malignancies. | Cell Commun Signal | 2024 | 38195556 | PubTator, text mining | PubMed |
| Whole-exome sequencing of Nigerian benign prostatic hyperplasia reveals increased alterations in apoptotic pathways. | Prostate | 2024 | 38192023 | PubTator, text mining | PubMed |
| A novel prognostic signature and therapy guidance for hepatocellular carcinoma based on STEAP family. | BMC Med Genomics | 2024 | 38191397 | PubTator, text mining | PubMed |
| A disulfidptosis-related lncRNAs signature in hepatocellular carcinoma: prognostic prediction, tumor immune microenvironment and drug susceptibility. | Sci Rep | 2024 | 38185671 | PubTator, text mining | PubMed |
| Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres. | J Transl Med | 2024 | 38184610 | PubTator, text mining | PubMed |
| Clinical applications and perspectives of circulating tumor DNA in gastric cancer. | Cancer Cell Int | 2024 | 38184573 | PubTator, text mining | PubMed |
| Lipid metabolism-derived FAAH is a sensitive marker for the prognosis and immunotherapy of osteosarcoma patients. | Heliyon | 2024 | 38169921 | PubTator, text mining | PubMed |
| Histone acetylation in an Alzheimer's disease cell model promotes homeostatic amyloid-reducing pathways. | Acta Neuropathol Commun | 2024 | 38167174 | PubTator, text mining | PubMed |
| Screening of novel tumor-associated antigens for lung adenocarcinoma mRNA vaccine development based on pyroptosis phenotype genes. | BMC Cancer | 2024 | 38166691 | PubTator, text mining | PubMed |
| Genomic characterization of vulvar squamous cell carcinoma reveals differential gene expression based on clinical outcome. | Gynecol Oncol | 2024 | 38086165 | PubTator, text mining | PubMed |
| Multi-omics approach for identifying CNV-associated lncRNA signatures with prognostic value in prostate cancer. | Noncoding RNA Res | 2024 | 38075203 | PubTator, text mining | PubMed |
| Current status and perspectives of genetic testing in gastrointestinal cancer (Review). | Oncol Lett | 2024 | 38058469 | PubTator, text mining | PubMed |
| Genomic landscape of patients with germline RUNX1 variants and familial platelet disorder with myeloid malignancy. | Blood Adv | 2024 | 38019014 | PubTator, text mining | PubMed |
| Pan-Cancer Single-Nucleus Total RNA Sequencing Using snHH-Seq. | Adv Sci (Weinh) | 2024 | 38010945 | PubTator, text mining | PubMed |
| DNA Mutational Profiling in Patients With Colorectal Cancer Treated With Standard of Care Reveals Differences in Outcome and Racial Distribution of Mutations. | J Clin Oncol | 2024 | 37992266 | PubTator, text mining | PubMed |
| Co-mutation of TP53 and TTN is Correlated with the Efficacy of Immunotherapy in Lung Squamous Cell Carcinoma. | Comb Chem High Throughput Screen | 2024 | 37904553 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53353/papers?page=9